Third-generation long-acting β₂-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β₂-adrenoceptor agonists.
about
Nonhuman targets in allergic lung conditions.Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators.Inhalation by design.Pharmacotherapy of Chronic Obstructive Pulmonary Disease: A Clinical Review
P2860
Third-generation long-acting β₂-adrenoceptor agonists: medicinal chemistry strategies employed in the identification of once-daily inhaled β₂-adrenoceptor agonists.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Third-generation long-acting β ...... aled β₂-adrenoceptor agonists.
@en
Third-generation long-acting β ...... aled β₂-adrenoceptor agonists.
@nl
type
label
Third-generation long-acting β ...... aled β₂-adrenoceptor agonists.
@en
Third-generation long-acting β ...... aled β₂-adrenoceptor agonists.
@nl
prefLabel
Third-generation long-acting β ...... aled β₂-adrenoceptor agonists.
@en
Third-generation long-acting β ...... aled β₂-adrenoceptor agonists.
@nl
P2860
P356
P1476
Third-generation long-acting β ...... aled β₂-adrenoceptor agonists.
@en
P2093
John R Jacobsen
P2860
P304
P356
10.4155/FMC.11.116
P577
2011-10-01T00:00:00Z